|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-5-27
|
|
pubmed:abstractText |
To evaluate hormonal suppression and pubertal development in children with central precocious puberty (CPP) after injection of triptoreline 11.25 mg (Diphereline S. R. 11.25 mg; Ipsen) in the first treatment cycle of 12 weeks.
|
|
pubmed:language |
cze
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1210-7832
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
107-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15918263-Child,
pubmed-meshheading:15918263-Child, Preschool,
pubmed-meshheading:15918263-Female,
pubmed-meshheading:15918263-Gonadal Steroid Hormones,
pubmed-meshheading:15918263-Gonadotropins, Pituitary,
pubmed-meshheading:15918263-Humans,
pubmed-meshheading:15918263-Male,
pubmed-meshheading:15918263-Puberty, Precocious,
pubmed-meshheading:15918263-Sexual Maturation,
pubmed-meshheading:15918263-Triptorelin Pamoate
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
[Hormonal suppression and sexual development in children with central precocious puberty in the first treatment cycle 12 weeks after injection of triptoreline 11.25 mg (Diphereline S. R. 11.25 mg): a pilot study].
|
|
pubmed:affiliation |
Pediatricka klinika 2, LF UK a FN Motol, Praha. marta.snajderova@lfmotol.cuni.cz
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
